Biology Reference
In-Depth Information
Kwon, H., Bai, Q., Baek, H. J., Felmet, K., Burton, E. A., Goins, W. F., Cohen, J. B., and
Glorioso, J. C. (2006). Soluble V domain of Nectin-1/HveC enables entry of herpes simplex
virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D.
J. Virol. 80,
138-148.
Labonte, P., Begley, S., Guevin, C., Asselin, M. C., Nassoury, N., Mayer, G., Prat, A., and
Seidah, N. G. (2009). PCSK9 impedes hepatitis C virus infection in vitro and modulates liver
CD81 expression. Hepatology 50, 17-24.
Labonte, P., and Seidah, N. G. (2008). Emerging viruses: risk of pandemic. Expert Rev Anti Infect Ther
6, 581-583.
Lahlil, R., Calvo, F., and Khatib, A. M. (2009). The potential anti-tumorigenic and anti-metastatic
side of the proprotein convertases inhibitors. Recent Pat. Anticancer Drug Discov. 4, 83-91.
Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T.,
Erickson, J., Merutka, G., and Petteway, S. R., Jr. (1996). Peptides from conserved regions of
paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.
Proc. Natl. Acad. Sci. USA
93, 2186-2191.
Larson, R. A., Dai, D., Hosack, V. T., Tan, Y., Bolken, T. C., Hruby, D. E., and Amberg, S. M.
(2008). Identification of a broad-spectrum arenavirus entry inhibitor.
J. Virol. 82, 10768-10775.
Lavillette, D., Maurice, M., Roche, C., Russell, S. J., Sitbon, M., and Cosset, F. L. (1998). A proline-
rich motif downstream of the receptor binding domain modulates conformation and fusogenicity
of murine retroviral envelopes.
J. Virol. 72, 9955-9965.
Lavillette, D., Ruggieri, A., Russell, S. J., and Cosset, F. L. (2000). Activation of a cell entry pathway
common to type C mammalian retroviruses by soluble envelope fragments.
J. Virol. 74, 295-304.
Lavillette, D., Marin, M., Ruggieri, A., Mallet, F., Cosset, F. L., and Kabat, D. (2002). The envelope
glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid
transporters/cell surface receptors.
J. Virol. 76, 6442-6452.
Lavillette, D., Tarr, A. W., Voisset, C., Donot, P., Bartosch, B., Bain, C., Patel, A. H., Dubuisson, J.,
Ball, J. K., and Cosset, F. L. (2005). Characterization of host-range and cell entry properties of the
major genotypes and subtypes of hepatitis C virus. Hepatology 41, 265-274.
Law, M., Maruyama, T., Lewis, J., Giang, E., Tarr, A. W., Stamataki, Z., Gastaminza, P.,
Chisari, F. V., Jones, I. M., Fox, R. I., Ball, J. K., McKeating, J. A., et al. (2008). Broadly
neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 14,
25-27.
Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., and Saphire, E. O. (2008).
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature
454, 177-182.
Lenz, O., ter Meulen, J., Klenk, H. D., Seidah, N. G., and Garten, W. (2001). The Lassa virus
glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl. Acad.
Sci. USA 98, 12701-12705.
Leonard, J. T., and Roy, K. (2006). The HIV entry inhibitors revisited.
Curr. Med. Chem. 13,
911-934.
Lescar, J., Roussel, A., Wien, M. W., Navaza, J., Fuller, S. D., Wengler, G., and Rey, F. A. (2001).
The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for
fusogenic activation at endosomal pH.
Cell 105, 137-148.
Li, M., Yang, C., Tong, S., Weidmann, A., and Compans, R. W. (2002). Palmitoylation of the
murine leukemia virus envelope protein is critical for lipid raft association and surface expression.
J. Virol. 76, 11845-11852.
Li, K., Zhang, S., Kronqvist, M., Wallin, M., Ekstrom, M., Derse, D., and Garoff, H. (2008).
Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus
Env.
J. Virol. 82, 7135-7143.
